Industry Research Reports
Home > Reports > Service & Software > Global Hemocompatibility Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Hemocompatibility Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-12
Pages: 149 Pages
Report ld: 6216146
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemocompatibility Testing Service Market Size(US$)
CAGR 2026-2032
7.3%
Market Size,2032
USD 148
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 97 million
Market Forecast in 2032(Value)
US$ 148 million
CAGR
7.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemocompatibility Testing Service market is projected to grow from US$ 91 million in 2025 to US$ 148 million by 2032, at a CAGR of 7.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Hemocompatibility testing service refers to a specialized analytical evaluation conducted to assess how biological materials, medical devices, or pharmaceuticals interact with blood components, ensuring they do not trigger adverse reactions such as thrombosis, hemolysis, inflammation, or immune responses. This service involves in vitro (test tube) and sometimes in vivo (animal model) assessments to measure parameters like blood cell adhesion, platelet activation, complement system activation, and coagulation factor disruption. It is crucial for the development and regulatory approval of medical products such as implants, catheters, artificial organs, or drug delivery systems, as non-hemocompatible materials can lead to life-threatening complications in patients. By simulating physiological conditions, these tests help manufacturers and researchers validate the safety of materials before human use, ensuring they integrate with the body’s circulatory system without compromising blood integrity or function.
From a downstream perspective, Medical Device Development accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Hemocompatibility Testing Service leading players (including Matexcel, Eurofins, Nelson Laboratories, LLC, Haemoscan, Measurlabs, STEMart, NAMSA, Lupine Medical, Eurolab, Nucro-Technics, etc.), dominate supply; the top five capture approximately % of global revenue, with Matexcel leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Hemocompatibility Testing Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Matexcel
- Eurofins
- Nelson Laboratories, LLC
- Haemoscan
- Measurlabs
- STEMart
- NAMSA
- Lupine Medical
- Eurolab
- Nucro-Technics
- TÜV SÜD
- Eucerep
- UL Solutions
- Level Biotechnology Inc.
- Cosmos Biomed Consulting
- Charles River Laboratories
- Ceshigo
- Kerbio
- Weike Inspection Group
- CTI
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Hemolysis Testing
- Complement Activation Testing
- Platelet Activation Testing
- Thrombogenicity Testing
- Coagulation Testing
- Others
Segment by Application
- Medical Device Development
- Biomedical Materials Research
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Hemocompatibility Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Hemocompatibility Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hemocompatibility Testing Service Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Hemolysis Testing
1.2.3 Complement Activation Testing
1.2.4 Platelet Activation Testing
1.2.5 Thrombogenicity Testing
1.2.6 Coagulation Testing
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Hemocompatibility Testing Service Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Medical Device Development
1.3.3 Biomedical Materials Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hemocompatibility Testing Service Revenue Estimates and Forecasts (2021-2032)
2.2 Global Hemocompatibility Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Hemocompatibility Testing Service Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Hemocompatibility Testing Service Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Hemolysis Testing: Market Share by Key Players
3.3.2 Complement Activation Testing: Market Share by Key Players
3.3.3 Platelet Activation Testing: Market Share by Key Players
3.3.4 Thrombogenicity Testing: Market Share by Key Players
3.3.5 Coagulation Testing: Market Share by Key Players
3.3.6 Others: Market Share by Key Players
3.4 Global Hemocompatibility Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Hemocompatibility Testing Service Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Hemocompatibility Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Hemocompatibility Testing Service Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Hemocompatibility Testing Service Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Hemocompatibility Testing Service Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Hemocompatibility Testing Service Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Hemocompatibility Testing Service Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Hemocompatibility Testing Service Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Hemocompatibility Testing Service Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Hemocompatibility Testing Service Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Hemocompatibility Testing Service Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Hemocompatibility Testing Service Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Matexcel
11.1.1 Matexcel Corporation Information
11.1.2 Matexcel Business Overview
11.1.3 Matexcel Hemocompatibility Testing Service Product Features and Attributes
11.1.4 Matexcel Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.1.5 Matexcel Hemocompatibility Testing Service Revenue by Product in 2025
11.1.6 Matexcel Hemocompatibility Testing Service Revenue by Application in 2025
11.1.7 Matexcel Hemocompatibility Testing Service Revenue by Geographic Area in 2025
11.1.8 Matexcel Hemocompatibility Testing Service SWOT Analysis
11.1.9 Matexcel Recent Developments
11.2 Eurofins
11.2.1 Eurofins Corporation Information
11.2.2 Eurofins Business Overview
11.2.3 Eurofins Hemocompatibility Testing Service Product Features and Attributes
11.2.4 Eurofins Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.2.5 Eurofins Hemocompatibility Testing Service Revenue by Product in 2025
11.2.6 Eurofins Hemocompatibility Testing Service Revenue by Application in 2025
11.2.7 Eurofins Hemocompatibility Testing Service Revenue by Geographic Area in 2025
11.2.8 Eurofins Hemocompatibility Testing Service SWOT Analysis
11.2.9 Eurofins Recent Developments
11.3 Nelson Laboratories, LLC
11.3.1 Nelson Laboratories, LLC Corporation Information
11.3.2 Nelson Laboratories, LLC Business Overview
11.3.3 Nelson Laboratories, LLC Hemocompatibility Testing Service Product Features and Attributes
11.3.4 Nelson Laboratories, LLC Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.3.5 Nelson Laboratories, LLC Hemocompatibility Testing Service Revenue by Product in 2025
11.3.6 Nelson Laboratories, LLC Hemocompatibility Testing Service Revenue by Application in 2025
11.3.7 Nelson Laboratories, LLC Hemocompatibility Testing Service Revenue by Geographic Area in 2025
11.3.8 Nelson Laboratories, LLC Hemocompatibility Testing Service SWOT Analysis
11.3.9 Nelson Laboratories, LLC Recent Developments
11.4 Haemoscan
11.4.1 Haemoscan Corporation Information
11.4.2 Haemoscan Business Overview
11.4.3 Haemoscan Hemocompatibility Testing Service Product Features and Attributes
11.4.4 Haemoscan Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.4.5 Haemoscan Hemocompatibility Testing Service Revenue by Product in 2025
11.4.6 Haemoscan Hemocompatibility Testing Service Revenue by Application in 2025
11.4.7 Haemoscan Hemocompatibility Testing Service Revenue by Geographic Area in 2025
11.4.8 Haemoscan Hemocompatibility Testing Service SWOT Analysis
11.4.9 Haemoscan Recent Developments
11.5 Measurlabs
11.5.1 Measurlabs Corporation Information
11.5.2 Measurlabs Business Overview
11.5.3 Measurlabs Hemocompatibility Testing Service Product Features and Attributes
11.5.4 Measurlabs Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.5.5 Measurlabs Hemocompatibility Testing Service Revenue by Product in 2025
11.5.6 Measurlabs Hemocompatibility Testing Service Revenue by Application in 2025
11.5.7 Measurlabs Hemocompatibility Testing Service Revenue by Geographic Area in 2025
11.5.8 Measurlabs Hemocompatibility Testing Service SWOT Analysis
11.5.9 Measurlabs Recent Developments
11.6 STEMart
11.6.1 STEMart Corporation Information
11.6.2 STEMart Business Overview
11.6.3 STEMart Hemocompatibility Testing Service Product Features and Attributes
11.6.4 STEMart Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.6.5 STEMart Recent Developments
11.7 NAMSA
11.7.1 NAMSA Corporation Information
11.7.2 NAMSA Business Overview
11.7.3 NAMSA Hemocompatibility Testing Service Product Features and Attributes
11.7.4 NAMSA Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.7.5 NAMSA Recent Developments
11.8 Lupine Medical
11.8.1 Lupine Medical Corporation Information
11.8.2 Lupine Medical Business Overview
11.8.3 Lupine Medical Hemocompatibility Testing Service Product Features and Attributes
11.8.4 Lupine Medical Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.8.5 Lupine Medical Recent Developments
11.9 Eurolab
11.9.1 Eurolab Corporation Information
11.9.2 Eurolab Business Overview
11.9.3 Eurolab Hemocompatibility Testing Service Product Features and Attributes
11.9.4 Eurolab Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.9.5 Eurolab Recent Developments
11.10 Nucro-Technics
11.10.1 Nucro-Technics Corporation Information
11.10.2 Nucro-Technics Business Overview
11.10.3 Nucro-Technics Hemocompatibility Testing Service Product Features and Attributes
11.10.4 Nucro-Technics Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 TÜV SÜD
11.11.1 TÜV SÜD Corporation Information
11.11.2 TÜV SÜD Business Overview
11.11.3 TÜV SÜD Hemocompatibility Testing Service Product Features and Attributes
11.11.4 TÜV SÜD Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.11.5 TÜV SÜD Recent Developments
11.12 Eucerep
11.12.1 Eucerep Corporation Information
11.12.2 Eucerep Business Overview
11.12.3 Eucerep Hemocompatibility Testing Service Product Features and Attributes
11.12.4 Eucerep Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.12.5 Eucerep Recent Developments
11.13 UL Solutions
11.13.1 UL Solutions Corporation Information
11.13.2 UL Solutions Business Overview
11.13.3 UL Solutions Hemocompatibility Testing Service Product Features and Attributes
11.13.4 UL Solutions Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.13.5 UL Solutions Recent Developments
11.14 Level Biotechnology Inc.
11.14.1 Level Biotechnology Inc. Corporation Information
11.14.2 Level Biotechnology Inc. Business Overview
11.14.3 Level Biotechnology Inc. Hemocompatibility Testing Service Product Features and Attributes
11.14.4 Level Biotechnology Inc. Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.14.5 Level Biotechnology Inc. Recent Developments
11.15 Cosmos Biomed Consulting
11.15.1 Cosmos Biomed Consulting Corporation Information
11.15.2 Cosmos Biomed Consulting Business Overview
11.15.3 Cosmos Biomed Consulting Hemocompatibility Testing Service Product Features and Attributes
11.15.4 Cosmos Biomed Consulting Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.15.5 Cosmos Biomed Consulting Recent Developments
11.16 Charles River Laboratories
11.16.1 Charles River Laboratories Corporation Information
11.16.2 Charles River Laboratories Business Overview
11.16.3 Charles River Laboratories Hemocompatibility Testing Service Product Features and Attributes
11.16.4 Charles River Laboratories Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.16.5 Charles River Laboratories Recent Developments
11.17 Ceshigo
11.17.1 Ceshigo Corporation Information
11.17.2 Ceshigo Business Overview
11.17.3 Ceshigo Hemocompatibility Testing Service Product Features and Attributes
11.17.4 Ceshigo Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.17.5 Ceshigo Recent Developments
11.18 Kerbio
11.18.1 Kerbio Corporation Information
11.18.2 Kerbio Business Overview
11.18.3 Kerbio Hemocompatibility Testing Service Product Features and Attributes
11.18.4 Kerbio Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.18.5 Kerbio Recent Developments
11.19 Weike Inspection Group
11.19.1 Weike Inspection Group Corporation Information
11.19.2 Weike Inspection Group Business Overview
11.19.3 Weike Inspection Group Hemocompatibility Testing Service Product Features and Attributes
11.19.4 Weike Inspection Group Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.19.5 Weike Inspection Group Recent Developments
11.20 CTI
11.20.1 CTI Corporation Information
11.20.2 CTI Business Overview
11.20.3 CTI Hemocompatibility Testing Service Product Features and Attributes
11.20.4 CTI Hemocompatibility Testing Service Revenue and Gross Margin (2021-2026)
11.20.5 CTI Recent Developments
12 Hemocompatibility Testing Service Value Chain and Ecosystem Analysis
12.1 Hemocompatibility Testing Service Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hemocompatibility Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Hemocompatibility Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Hemocompatibility Testing Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Hemocompatibility Testing Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Hemocompatibility Testing Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Hemocompatibility Testing Service Revenue by Region (US$ Million), 2021-2026
Table 5. Global Hemocompatibility Testing Service Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Hemocompatibility Testing Service Revenue by Players (US$ Million), 2021-2026
Table 8. Global Hemocompatibility Testing Service Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Hemocompatibility Testing Service Revenue, 2025
Table 11. Global Hemocompatibility Testing Service Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Hemocompatibility Testing Service Companies Headquarters
Table 13. Global Hemocompatibility Testing Service Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Hemocompatibility Testing Service Revenue by Type (US$ Million), 2021-2026
Table 17. Global Hemocompatibility Testing Service Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Hemocompatibility Testing Service Revenue by Application (US$ Million), 2021-2026
Table 20. Global Hemocompatibility Testing Service Revenue by Application (US$ Million), 2027-2032
Table 21. Hemocompatibility Testing Service High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Hemocompatibility Testing Service Growth Accelerators and Market Barriers
Table 25. North America Hemocompatibility Testing Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Hemocompatibility Testing Service Growth Accelerators and Market Barriers
Table 27. Europe Hemocompatibility Testing Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Hemocompatibility Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Hemocompatibility Testing Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Hemocompatibility Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Hemocompatibility Testing Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Hemocompatibility Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Hemocompatibility Testing Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Matexcel Corporation Information
Table 35. Matexcel Description and Major Businesses
Table 36. Matexcel Product Features and Attributes
Table 37. Matexcel Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Matexcel Revenue Proportion by Product in 2025
Table 39. Matexcel Revenue Proportion by Application in 2025
Table 40. Matexcel Revenue Proportion by Geographic Area in 2025
Table 41. Matexcel Hemocompatibility Testing Service SWOT Analysis
Table 42. Matexcel Recent Developments
Table 43. Eurofins Corporation Information
Table 44. Eurofins Description and Major Businesses
Table 45. Eurofins Product Features and Attributes
Table 46. Eurofins Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Eurofins Revenue Proportion by Product in 2025
Table 48. Eurofins Revenue Proportion by Application in 2025
Table 49. Eurofins Revenue Proportion by Geographic Area in 2025
Table 50. Eurofins Hemocompatibility Testing Service SWOT Analysis
Table 51. Eurofins Recent Developments
Table 52. Nelson Laboratories, LLC Corporation Information
Table 53. Nelson Laboratories, LLC Description and Major Businesses
Table 54. Nelson Laboratories, LLC Product Features and Attributes
Table 55. Nelson Laboratories, LLC Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Nelson Laboratories, LLC Revenue Proportion by Product in 2025
Table 57. Nelson Laboratories, LLC Revenue Proportion by Application in 2025
Table 58. Nelson Laboratories, LLC Revenue Proportion by Geographic Area in 2025
Table 59. Nelson Laboratories, LLC Hemocompatibility Testing Service SWOT Analysis
Table 60. Nelson Laboratories, LLC Recent Developments
Table 61. Haemoscan Corporation Information
Table 62. Haemoscan Description and Major Businesses
Table 63. Haemoscan Product Features and Attributes
Table 64. Haemoscan Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Haemoscan Revenue Proportion by Product in 2025
Table 66. Haemoscan Revenue Proportion by Application in 2025
Table 67. Haemoscan Revenue Proportion by Geographic Area in 2025
Table 68. Haemoscan Hemocompatibility Testing Service SWOT Analysis
Table 69. Haemoscan Recent Developments
Table 70. Measurlabs Corporation Information
Table 71. Measurlabs Description and Major Businesses
Table 72. Measurlabs Product Features and Attributes
Table 73. Measurlabs Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Measurlabs Revenue Proportion by Product in 2025
Table 75. Measurlabs Revenue Proportion by Application in 2025
Table 76. Measurlabs Revenue Proportion by Geographic Area in 2025
Table 77. Measurlabs Hemocompatibility Testing Service SWOT Analysis
Table 78. Measurlabs Recent Developments
Table 79. STEMart Corporation Information
Table 80. STEMart Description and Major Businesses
Table 81. STEMart Product Features and Attributes
Table 82. STEMart Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. STEMart Recent Developments
Table 84. NAMSA Corporation Information
Table 85. NAMSA Description and Major Businesses
Table 86. NAMSA Product Features and Attributes
Table 87. NAMSA Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. NAMSA Recent Developments
Table 89. Lupine Medical Corporation Information
Table 90. Lupine Medical Description and Major Businesses
Table 91. Lupine Medical Product Features and Attributes
Table 92. Lupine Medical Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Lupine Medical Recent Developments
Table 94. Eurolab Corporation Information
Table 95. Eurolab Description and Major Businesses
Table 96. Eurolab Product Features and Attributes
Table 97. Eurolab Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Eurolab Recent Developments
Table 99. Nucro-Technics Corporation Information
Table 100. Nucro-Technics Description and Major Businesses
Table 101. Nucro-Technics Product Features and Attributes
Table 102. Nucro-Technics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Nucro-Technics Recent Developments
Table 104. TÜV SÜD Corporation Information
Table 105. TÜV SÜD Description and Major Businesses
Table 106. TÜV SÜD Product Features and Attributes
Table 107. TÜV SÜD Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. TÜV SÜD Recent Developments
Table 109. Eucerep Corporation Information
Table 110. Eucerep Description and Major Businesses
Table 111. Eucerep Product Features and Attributes
Table 112. Eucerep Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Eucerep Recent Developments
Table 114. UL Solutions Corporation Information
Table 115. UL Solutions Description and Major Businesses
Table 116. UL Solutions Product Features and Attributes
Table 117. UL Solutions Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. UL Solutions Recent Developments
Table 119. Level Biotechnology Inc. Corporation Information
Table 120. Level Biotechnology Inc. Description and Major Businesses
Table 121. Level Biotechnology Inc. Product Features and Attributes
Table 122. Level Biotechnology Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Level Biotechnology Inc. Recent Developments
Table 124. Cosmos Biomed Consulting Corporation Information
Table 125. Cosmos Biomed Consulting Description and Major Businesses
Table 126. Cosmos Biomed Consulting Product Features and Attributes
Table 127. Cosmos Biomed Consulting Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Cosmos Biomed Consulting Recent Developments
Table 129. Charles River Laboratories Corporation Information
Table 130. Charles River Laboratories Description and Major Businesses
Table 131. Charles River Laboratories Product Features and Attributes
Table 132. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Charles River Laboratories Recent Developments
Table 134. Ceshigo Corporation Information
Table 135. Ceshigo Description and Major Businesses
Table 136. Ceshigo Product Features and Attributes
Table 137. Ceshigo Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. Ceshigo Recent Developments
Table 139. Kerbio Corporation Information
Table 140. Kerbio Description and Major Businesses
Table 141. Kerbio Product Features and Attributes
Table 142. Kerbio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. Kerbio Recent Developments
Table 144. Weike Inspection Group Corporation Information
Table 145. Weike Inspection Group Description and Major Businesses
Table 146. Weike Inspection Group Product Features and Attributes
Table 147. Weike Inspection Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. Weike Inspection Group Recent Developments
Table 149. CTI Corporation Information
Table 150. CTI Description and Major Businesses
Table 151. CTI Product Features and Attributes
Table 152. CTI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. CTI Recent Developments
Table 154. Technologies, Platforms and Infrastructure
Table 155. Distributors List
Table 156. Market Trends and Market Evolution
Table 157. Market Drivers and Opportunities
Table 158. Market Challenges, Risks, and Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemocompatibility Testing Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Hemolysis Testing Product Picture
Figure 3. Complement Activation Testing Product Picture
Figure 4. Platelet Activation Testing Product Picture
Figure 5. Thrombogenicity Testing Product Picture
Figure 6. Coagulation Testing Product Picture
Figure 7. Others Product Picture
Figure 8. Global Hemocompatibility Testing Service Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Global Hemocompatibility Testing Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Medical Device Development
Figure 11. Biomedical Materials Research
Figure 12. Others
Figure 13. Hemocompatibility Testing Service Report Years Considered
Figure 14. Global Hemocompatibility Testing Service Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 16. Global Hemocompatibility Testing Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Global Hemocompatibility Testing Service Revenue-Based Market Share by Region (2021-2032)
Figure 18. Global Hemocompatibility Testing Service Revenue-Based Market Share Ranking (2025)
Figure 19. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 20. Hemolysis Testing Revenue-Based Market Share by Player in 2025
Figure 21. Complement Activation Testing Revenue-Based Market Share by Player in 2025
Figure 22. Platelet Activation Testing Revenue-Based Market Share by Player in 2025
Figure 23. Thrombogenicity Testing Revenue-Based Market Share by Player in 2025
Figure 24. Coagulation Testing Revenue-Based Market Share by Player in 2025
Figure 25. Others Revenue-Based Market Share by Player in 2025
Figure 26. Global Hemocompatibility Testing Service Revenue-Based Market Share by Type (2021-2032)
Figure 27. Global Hemocompatibility Testing Service Revenue-Based Market Share by Application (2021-2032)
Figure 28. North America Hemocompatibility Testing Service Revenue YoY (US$ Million), 2021-2032
Figure 29. North America Top 5 Players Hemocompatibility Testing Service Revenue (US$ Million) in 2025
Figure 30. North America Hemocompatibility Testing Service Revenue (US$ Million) by Application (2021-2032)
Figure 31. US Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 32. Canada Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 33. Mexico Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 34. Europe Hemocompatibility Testing Service Revenue YoY (US$ Million), 2021-2032
Figure 35. Europe Top 5 Players Hemocompatibility Testing Service Revenue (US$ Million) in 2025
Figure 36. Europe Hemocompatibility Testing Service Revenue (US$ Million) by Application (2021-2032)
Figure 37. Germany Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 38. France Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 39. U.K. Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 40. Italy Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 41. Russia Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 42. Asia-Pacific Hemocompatibility Testing Service Revenue YoY (US$ Million), 2021-2032
Figure 43. Asia-Pacific Top 8 Players Hemocompatibility Testing Service Revenue (US$ Million) in 2025
Figure 44. Asia-Pacific Hemocompatibility Testing Service Revenue (US$ Million) by Application (2021-2032)
Figure 45. Indonesia Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 46. Japan Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 47. South Korea Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 48. Australia Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 49. India Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 50. Indonesia Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 51. Vietnam Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 52. Malaysia Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 53. Philippines Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 54. Singapore Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 55. Central and South America Hemocompatibility Testing Service Revenue YoY (US$ Million), 2021-2032
Figure 56. Central and South America Top 5 Players Hemocompatibility Testing Service Revenue (US$ Million) in 2025
Figure 57. Central and South America Hemocompatibility Testing Service Revenue (US$ Million) by Application (2021-2032)
Figure 58. Brazil Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 59. Argentina Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 60. Middle East and Africa Hemocompatibility Testing Service Revenue YoY (US$ Million), 2021-2032
Figure 61. Middle East and Africa Top 5 Players Hemocompatibility Testing Service Revenue (US$ Million) in 2025
Figure 62. Middle East and Africa Hemocompatibility Testing Service Revenue (US$ Million) by Application (2021-2032)
Figure 63. GCC Countries Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 64. Israel Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 65. Egypt Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 66. South Africa Hemocompatibility Testing Service Revenue (US$ Million), 2021-2032
Figure 67. Hemocompatibility Testing Service Value Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Hemocompatibility Testing Service in 2032?
What is the annual compound growth rate of the global Hemocompatibility Testing Service market size from 2026 to 2032?
What was the global market size of Hemocompatibility Testing Service in 2026?
Which companies rank high in the global Hemocompatibility Testing Service market?
Related Reports
Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemocompatibility Testing Service market size was US$ 91 million in 2025 and is forecast to reach a readjusted size of US$ 148 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 101
USD 4250.00
(Single User License)
Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemocompatibility Testing Service was estimated to be worth US$ 91 million in 2025 and is projected to reach US$ 148 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 130
USD 3950.00
(Single User License)
Global Hemocompatibility Testing Service Market Research Report 2026
The global Hemocompatibility Testing Service market was valued at US$ 91 million in 2025 and is anticipated to reach US$ 148 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 129
USD 2900.00
(Single User License)
Global Hemocompatibility Testing Service Market Research Report 2025
The global market for Hemocompatibility Testing Service was valued at US$ 83.0 million in the year 2024 and is projected to reach a revised size of US$ 139 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-06-07
Pages: 92
USD 2900.00
(Single User License)
Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemocompatibility Testing Service was estimated to be worth US$ 83.0 million in 2024 and is forecast to a readjusted size of US$ 139 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-06-07
Pages: 134
USD 3950.00
(Single User License)
Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemocompatibility Testing Service market size was US$ 83.0 million in 2024 and is forecast to a readjusted size of US$ 139 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-06-07
Pages: 107
USD 4250.00
(Single User License)
Global Hemocompatibility Testing Service Market Insights, Forecast to 2031
The global Hemocompatibility Testing Service market is projected to grow from US$ 91.0 million in 2025 to US$ 139 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.
Published Date: 2025-06-07
Pages: 147
USD 4900.00
(Single User License)
Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemocompatibility Testing Service market size was US$ 91 million in 2025 and is forecast to reach a readjusted size of US$ 148 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 101
USD 4250.00 (Single User License)Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemocompatibility Testing Service was estimated to be worth US$ 91 million in 2025 and is projected to reach US$ 148 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 130
USD 3950.00 (Single User License)Global Hemocompatibility Testing Service Market Research Report 2026
The global Hemocompatibility Testing Service market was valued at US$ 91 million in 2025 and is anticipated to reach US$ 148 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 129
USD 2900.00 (Single User License)Global Hemocompatibility Testing Service Market Research Report 2025
The global market for Hemocompatibility Testing Service was valued at US$ 83.0 million in the year 2024 and is projected to reach a revised size of US$ 139 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-06-07
Pages: 92
USD 2900.00 (Single User License)Hemocompatibility Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemocompatibility Testing Service was estimated to be worth US$ 83.0 million in 2024 and is forecast to a readjusted size of US$ 139 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-06-07
Pages: 134
USD 3950.00 (Single User License)Global Hemocompatibility Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemocompatibility Testing Service market size was US$ 83.0 million in 2024 and is forecast to a readjusted size of US$ 139 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-06-07
Pages: 107
USD 4250.00 (Single User License)Global Hemocompatibility Testing Service Market Insights, Forecast to 2031
The global Hemocompatibility Testing Service market is projected to grow from US$ 91.0 million in 2025 to US$ 139 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.
Published: 2025-06-07
Pages: 147
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now